DURING DEVELOPMENT, LUNG MORPHOGENESIS is initiated when the lung bud evaginates from the foregut endoderm. Subsequently, the airway tree is generated as the cells of the lung bud are induced to begin a program of repeated branching to establish airways lined with epithelium. As development proceeds, regional differentiation along the airway epithelium results in multiple subpopulations of cells with distinct functions. The cellular differentiation is accompanied by expression of differentiation markers that reflects the degree of maturation of the lung epithelium. Lung development is a multistep process, utilizing numerous transcription factors to control the cellular differentiation of multipotential progenitors (16, 29, 45, 77, 78) . Recent evidence suggests that members of the CCAAT/ enhancer binding protein (C/EBP) family play important roles in lung development and lung-specific gene expression. The C/EBP transcription factors form a family within the basic region-leucine zipper (bZIP) class of transcription factors. C/EBPs are expressed in several organs and are involved in controlling differentiation-dependent gene expression. Individual members of this family have additional specific roles; some control other differentiation-dependent processes such as inhibition of proliferation, and other members are involved in regulation of inflammatory genes. In the lung, C/EBP␣, -␤, and -␦ are expressed as well as the two ubiquitously expressed family members C/EBP␥ and - (58) . During the last five years, the biological role of these transcription factors in lung has started to emerge, and in this review we give an overview of the current understanding of their role in the lung epithelium. In the lung, these factors play a role in inflammation, similar to other organs. However, as this has been touched on in several recent reviews (see for instance Refs. 24, 56, 58), we only briefly discuss these aspects of C/EBP function in the lung.
THE C/EBP TRANSCRIPTION FACTOR FAMILY
Structure and expression. C/EBP factors belong to the bZIP class of basic domain transcription factors (81, 82) . Six members (C/EBP␣-) constitute the mammalian C/EBP family. Of these, C/EBP␣ was first identified and is the founding member. The basic region of C/EBP factors is a highly positively charged domain that directly interacts with the DNA (see Fig. 1 ). All members of the C/EBP family have similar basic region DNA-binding motifs except C/EBP (which lacks DNAbinding activity). As a consequence of the high similarity in the basic region, C/EBP␣, C/EBP␤, and C/EBP␦ have been shown to interact with virtually identical DNA sequences (6, 53, 80) . The leucine zipper region is also conserved between the different family members, whereas the amino-terminal transactivation domain is more diverse. The leucine zipper domain is involved in homo-and heterodimerization, and all proteins in the C/EBP family have been shown to form homo-and heterodimers. Of the tissue-specific C/EBP family members, three have been demonstrated to be expressed in lung, namely C/EBP␣, -␤, and -␦ (6, 80) . Although C/EBP␣ and -␤ are expressed at highest relative levels in the liver and fat, C/EBP␦ is expressed at highest levels in the lung (6) . C/EBP factors have been suggested to play important roles in controlling differentiation. In liver, fat, and white blood cells of the myelomonocytic lineage, C/EBP factors have been demonstrated to be important regulators of different aspects of differentiation, including proliferation, cell cycle arrest, and gene expression (reviewed in Refs. 18, 21, 22, 39, 56) .
Expression pattern in lung. A similar role in lung cellular differentiation is suggested by the expression of C/EBP␣ in the developing lung; expression is initiated in close temporal proximity to the initiation of cellular differentiation and the appearance of differentiation markers (Ref. 40 ; T. Berg and M. Nord, unpublished observations; Fig. 2 ). In the adult lung, C/EBP␣ is expressed in the type II cells of the alveolar epithelium, and lower levels are also seen in the bronchiolar epithelial Clara cells, as revealed by immunohistochemical studies and studies on isolated epithelial cells (9, 40, 51, 69) . C/EBP␤ is expressed in type II cells of the alveolar region (61, 69) , and expression is also seen in the bronchiolar epithelium (T. Berg, T. N. Cassel, and M. Nord, unpublished observations). C/EBP␦ shows high-level expression in the bronchiolar epithelium and lower levels in alveolar type II cells (9, 37, 61, 69) . The developmental expression pattern of C/EBP␤ and -␦ has not been investigated by immunohistochemical methods, but analyses on whole embryonic lung show that these factors also increase late during development (5, 61) . However, their temporal expression patterns seem to precede that of C/EBP␣, similar to what has been demonstrated during adipocyte differentiation (21) . An important role of C/EBP␣ in lung cellular differentiation is suggested by the phenotype of the C/EBP␣(Ϫ/Ϫ) mouse. The phenotype is lethal, and mice die within 10 h after birth due to severe hypoglycemia (27, 76) . However, a fraction of C/EBP␣(Ϫ/Ϫ) mice succumbs immediately after birth from apparent respiratory distress (27) . Closer examinations revealed impaired lung cellular differentiation with abnormalities in the alveolar epithelium and hyperproliferation of type II cells (27, 68) . No lung phenotype has been reported in the C/EBP␤(Ϫ/Ϫ), C/EBP␦(Ϫ/Ϫ), or C/EBP␤(Ϫ/Ϫ)/C/EBP␦(Ϫ/Ϫ) doubleknockout mice (63, 66, 70) .
Role for C/EBP transcription factors in lung epithelial differentiation? Studies in transgenic and knockout mice have revealed that forkhead box transcription factors, especially FoxA2/hepatocyte nuclear factor (HNF)-3␤ and the homeodomain transcription factor Nkx2.1/thyroid transcription factor (TTF)-1, play major roles in cellular differentiation of the lung epithelium, as well as specifying developmental processes in the early developing lung (2, 35, 46, 47, 79, 84) . This is in agreement with the expression pattern of these transcription factors. They are turned on at an early time point in lung development and are sustained in the epithelium throughout lung development (3, 38, 48; Fig. 2) . As the expression of HNF-3 factors and Nkx2.1 is initiated from an early time point of lung development, additional transcription factors are likely to be important to promote the extensive cellular differentiation program that is initiated in late lung development. Several lines of reasoning support the concept that C/EBP factors could be important for cellular differentiation during late lung development; C/EBP transcription factors have been demonstrated to play important roles in cellular differentiation in a variety of different tissues including breast, adipocytes, white blood cells, and liver. Notably, a relationship between lung and liver transcriptional regulation is likely, as suggested by their shared endodermal origin, the important role of HNF-3 factors, and the expression of C/EBP factors in both organs. Moreover, C/EBP transcription factors, including C/EBP␣, C/EBP␤, and C/EBP␦, are expressed in the lung, and their expression is initiated in temporal proximity to the initiation of cellular differentiation and the appearance of differentiation markers. And finally, C/EBP␣(Ϫ/Ϫ) mice demonstrate morphological abnormalities with hyperproliferation of alveolar type II cells, indicating a role for C/EBP␣ in the control of proliferation-differentiation processes in the lung epithelium.
REGULATION OF LUNG GENE EXPRESSION
Clara cell secretory protein/secretoglobin 1a1. Clara cell secretory protein (CCSP)/secretoglobin 1a1 was the first lung-specific gene demonstrated to be regulated by C/EBP transcription factors in transcription regulation studies (9, 51) . On the basis of sequences in the promoter showing similarities to consensus C/EBP-binding sites and correlating expression patterns, C/EBP regulation of the surfactant protein (SP)-A gene has also been proposed (40) . CCSP is a small secretory protein abundantly expressed in the Clara cells of the bronchiolar epithelium and in similar cells in the larger airways (50) . Although the exact physiological role of CCSP remains to be established, it has been suggested that CCSP plays a role in protection against oxidative stress and/or has an anti-inflammatory function (67, 83) . CCSP is expressed in a differentiationdependent pattern in the developing lung, in temporal proximity to cellular differentiation (50) . Expression starts late in lung development in parallel with the appearance of Clara cells. Postnatally, the expression levels of CCSP continue to increase, and adult levels are not reached until the Clara cells are fully differentiated.
Freshly isolated primary Clara cells express high levels of CCSP. During culture in vitro, expression decreases. The expression of transcription factors such as HNF-3 and Nkx2.1, known to regulate CCSP gene expression, does not parallel the rapidly declining CCSP levels during culture in vitro. In contrast, C/EBP␣ expression is rapidly lost. The decrease in C/EBP␣ levels correlates to dedifferentiation of the cells and declining CCSP levels, suggesting a potential role of C/EBP␣ in the regulation of CCSP (51) . In addition to C/EBP␣, C/EBP␦ is expressed in the bronchiolar epithelium and also in isolated Clara cells (8, 9, 37) . A functional importance of both C/EBP␣ and C/EBP␦ for CCSP gene regulation has been demonstrated in transient transfection studies in lung epithelial cell lines. These studies showed that both C/EBP␣ and -␦ promote transcription and that this occurs through interaction with two C/EBP-binding sites in the proximal promoter (Ref. 9; Fig. 3 ). Mutation of either C/EBP-binding site resulted in abolished or strikingly reduced C/EBP␣-and C/EBP␦-mediated transactivation of the CCSP promoter, as well as impaired binding of both factors in DNase I footprint analysis. These results indicate that the two C/EBPbinding sites form a compound response element. Electrophoretic mobility shift assays showed that C/EBP␣ and -␦ can bind to both C/EBP-binding sites, whereas in DNase I footprint analyses, the interaction of C/EBP␣ with the proximal site was weak. To summarize, C/EBP␣ and C/EBP␦ activate the CCSP promoter via a compound response element in the proximal promoter. This element consists of two adjacent C/EBPbinding sites (Fig. 3 ) that individually can bind C/EBP␣ and C/EBP␦ with equal efficiency, but not in the context of the intact promoter. Together, this renders the C/EBP-mediated regulation of the CCSP gene a complicated process.
Combinatorial action of C/EBPs and other transcription factors. In the proximal CCSP promoter, located in a region between ϩ1 and Ϫ130 bp of the 5Ј flanking sequence, reside multiple cis-acting elements of potential importance to the promotion of the tissue and cell-specific expression of CCSP. In addition to the two adjacent C/EBP-binding sites, several functional binding sites for Nkx2.1/TTF-1 and FoxA/HNF-3 factors exist within this short region (Fig. 3) . The close proximity of binding sites for multiple transcription factors suggests combinatorial action in the regulation of the CCSP gene (50) . And indeed, in studies of transient transfection, a strong synergistic transactivation was observed between C/EBP␣ and Nkx2.1 on the CCSP promoter. The Nkx2.1-C/EBP␣ synergism was specific, as other combinations of transcription factors tested resulted in levels of transactivation that were approximately additive. The synergism is mediated through interaction with elements in the proximal CCSP promoter ( Fig. 3 ) and seems to be dependent on cooperative binding of the transcription factors to the promoter (7). These results demonstrate that C/EBP␣ acts to- gether with another lung-enriched transcription factor, Nkx2.1, in the regulation of CCSP. The strong synergistic activity, together with the temporal expression patterns of CCSP, C/EBP␣, and Nkx2.1, suggests that the appearance of C/EBP␣ in the developing lung is a key event to initiate high-level expression of CCSP in late lung development (Fig. 2) . With these results, together with the studies of targeted inactivation of C/EBP␣ and Nkx2.1 (27, 35) , the following model concerning the roles of C/EBP␣ and Nkx2.1 in the developing lung epithelium can be formulated: Nkx2.1 serves to specify lung epithelial cell lineage early in lung development and thus regulates lung-specific gene expression. C/EBP␣ has its main role in late development and acts as a regulator of differentiationdependent gene expression. A gene such as CCSP, which is specifically expressed in the lung epithelium and exhibits a differentiation-dependent expression pattern, would consequently be predicted to require simultaneous presence of Nkx2.1 and C/EBP␣ for highlevel expression (Figs. 2 and 3) . A role for C/EBP␣ in late lung development is also supported by the findings that C/EBP␣ expression is first detected when differentiation of secretory epithelial cells is initiated: differentiated type II cells appear in the future alveolar epithelium, and differentiation of the bronchiolar Clara cells starts. This is in close connection to the onset of high-level expression of genes with a differentiation-dependent expression pattern such as CCSP (Fig. 2) . However, full differentiation of Clara cells is attained postnatally (45, 71, 72) . In the postulated model, the appearance of C/EBP␣ in the developing lung epithelium is a key event to initiate expression of differentiated gene products, in a similar fashion as has been demonstrated in hepatocytes and adipocytes (6, 27, 32, 59, 74, 76) .
SP-A. SP-A is one of the hydrophilic surfactant proteins and is expressed in the alveolar type II cells as well as in bronchiolar Clara cells (36) . SP-A expression is initiated late in lung development and increases in concert with the appearance of differentiated type II cells (Fig. 2) . In the adult lung, SP-A is highly expressed in alveolar type II cells and to a lesser extent in Clara cells (45) . On the basis of sequences in the SP-A promoter showing similarities to consensus C/EBPbinding sites and correlations between SP-A and C/EBP␣ expression, regulation of this gene by C/EBP transcription factors has been proposed (40) . And recently, a functional C/EBP-binding site was demonstrated in the proximal rat SP-A gene at ϳ180 bp upstream of the start site of transcription (42, 61) . This element is necessary for full C/EBP␦ responsiveness of the promoter, and antisense knock-down of C/EBP␦ decreased expression of the endogenous SP-A gene in a human lung cancer cell line. These results demonstrate that C/EBP transcription factors regulate SP-A expression. Likewise, the expression patterns of SP-A and C/EBP factors suggest that C/EBP factors have a role in the differentiation-dependent expression of SP-A in the developing lung (Fig. 2) . Together, these studies suggest that C/EBP factors are involved in the regulation of differentiation-dependent gene expression in the alveolar epithelium as well.
SP-D.
A second hydrophilic surfactant protein found in lung lavage is SP-D. It is expressed in alveolar type II cells, in Clara cells, and in the tracheobronchial glands of the lung, but unlike other surfactant proteins, SP-D does not localize to lamellar bodies (36) . SP-D starts being expressed late in lung development, and expression continues to increase postnatally (Ref. 45 ; Fig. 2 ). Transfection studies in human lung cancer cells have revealed the presence of three functional C/EBP response elements in the promoter of the human SP-D gene (31) . Two are located close together at 340 and 319 bp upstream of the start site of transcription and the third further upstream at Ϫ432. The two sites positioned in tandem at Ϫ340 and Ϫ319 seem not to bind C/EBP factors simultaneously. However, these binding sites interact with the Ϫ432 site to fully transactivate the SP-D promoter. The presence of several interacting C/EBP-binding sites forms a common theme together with the CCSP promoter, which also contains two C/EBP-binding sites acting together. However, in contrast to the SP-D promoter, where the sites are situated nearly 100 bp apart, the cooperating C/EBP-binding sites in the CCSP promoter are separated by only 20 bp. From these results it seems that, similar to SP-A, C/EBP-factors are likely to be key regulators underlying the developmental expression of SP-D. In addition, both SP-A and -D are upregulated in response to acute-phase stimuli such as instillation of lipopolysaccharide (43) . As in the liver, C/EBP␤ and -␦ are increased in lung after acute-phase stimuli (1, 14) . This suggests that C/EBP␤ and -␦ could be involved in mediating the acute-phase response in lung, similar to what has been described in the liver.
CYP2B1. The P450 enzyme CYP2B1 is constitutively expressed in the lung epithelium, both in the Clara cells of the conducting airway epithelium and in the alveolar type II cells. In the lung epithelium, it also exhibits an expression pattern correlating to the extensive cellular differentiation occurring around the time of birth (Ref. 25 ; Fig. 2 ). Studies in cells of liver origin have demonstrated that the CYP2B1 gene is transactivated by C/EBP␣ and C/EBP␤ through a C/EBPbinding site in the proximal promoter (55), and transgenic studies have revealed that 1.3 kb of the 5Ј flanking region of the CYP2B1 promoter is sufficient to promote lung-specific expression (65) . In transient transfections in lung epithelial cells, reporter gene activity driven by 1,350 bp of the CYP2B1 promoter was increased by both C/EBP␣ and C/EBP␦, and inactivation of the C/EBP-binding site caused a significant reduction of the transactivation efficiency from both factors (8) . These results indicate that C/EBP␣ and C/EBP␦ are important in controlling CYP2B1 gene expression in lung epithelial cells and show that the proximal C/EBP-binding site confers C/EBP transactivation.
In summary, the results showing C/EBP regulation of the CCSP, SP-A and -D, and CYP2B1 genes indicate an important role for C/EBP transcription factors in regulating lung epithelial gene expression. All these genes show a similar differentiation-dependent expression pattern during lung development with an onset of high-level expression late in lung development (Fig. 2) , suggesting that they are regulated in a similar fashion. The expression pattern of C/EBPs during lung development parallels cellular differentiation, and C/EBP expression is initiated in close proximity to the onset of high-level expression of these genes (Fig. 2) . Together, this indicates that C/EBPs have a main role late in lung development as a regulator of differentiationdependent expression of this group of genes.
UNIQUE ROLES FOR THE DIFFERENT C/EBP FAMILY MEMBERS?
C/EBP␣. Results from targeted inactivation of the gene for C/EBP␣ in mice indicate a specific role for this transcription factor in regulating subsets of genes, especially in the liver, where genes involved in gluconeogenesis and glycogen synthesis exhibit specific decreases (18, 76) . Increased proliferation is also evident in the livers of C/EBP␣(Ϫ/Ϫ) mice (27) , and liver regeneration is associated with decreased C/EBP␣ expression. Moreover, forced expression of C/EBP␣ in liver cell lines inhibits proliferation. Together, this suggests a role for C/EBP␣ in regulating proliferation in the liver (22) . In the lung, knockout of C/EBP␣ has revealed a critical role in regulating proliferation of the alveolar epithelium as well (27, 68) . In contrast, expression of genes regulated by C/EBP factors is seemingly unaffected in the lungs of C/EBP␣(Ϫ/Ϫ) mice. This is most probably explained by other C/EBPs present in lung substituting for C/EBP␣ in the transactivation of target genes. An ability of C/EBP␤ to substitute for C/EBP␣ has indeed been demonstrated (12, 18, 19) . However, the idea that other C/EBPs can fully substitute for C/EBP␣ in transcriptional regulation in the lung is challenged by the finding of efficient synergism observed specifically between C/EBP␣ and Nkx2.1.
Our understanding of how C/EBP␣ regulates cellular proliferation was recently advanced by several studies; C/EBP␣ has been demonstrated to interact directly with the cyclin-dependent kinases (cdks) 2 and 4, two critical regulators of cell cycle progression (75) . Interaction occurs through a short region of the C/EBP␣ polypeptide and prevents interaction of these kinases with their cognate cyclins. As the cyclin-cdk interaction is necessary for activity of the cdks and progression through the cell cycle, this provides a potential mechanism for the growth arrest mediated by C/EBP␣. The closely related family members C/EBP␤ and -␦, which are expressed in proliferating cells, do not share this cdk-interacting region. In a separate study, in vivo experiments demonstrated that C/EBP␣ also represses the E2F complex and that this repression is necessary for terminal differentiation of fat cells and granulocytes (57) . Activation of the E2F complex is necessary for passage through the restriction point of the cell cycle and is thus central in regulation of proliferation. The E2F repression is mediated by regions of C/EBP␣ separate from the cdk-interacting region, suggesting the existence of two separate pathways for C/EBP␣ to inhibit proliferation. Notably, neither of these regions is involved in activating the conventional array of target genes for C/EBP␣ (44). An additional mechanism by which C/EBP␣ might inhibit proliferation is via transcriptional induction of the cdk inhibitor p21
. This mechanism seems to be especially important for the antiproliferative effects of glucocorticoids (10, 17) . Interestingly, in human lung mesenchymal cells, this effect has recently been demonstrated to be mediated by formation of a complex between the glucocorticoid receptor and C/EBP␣ (62) . All together, these mechanisms establish the means by which a single factor such as C/EBP␣ couples growth arrest to gene expression in the process referred to as differentiation and indicate that this dual activity is unique for C/EBP␣ (44) .
The hyperproliferative nature of the alveolar epithelium in mice lacking C/EBP␣ indicates that C/EBP␣ has a central role in controlling proliferation in the lung epithelium (27, 68) . Findings of dominant-negative mutations in the gene encoding C/EBP␣ in acute myeloid leukemias show that C/EBP␣ is a tumor suppressor gene (54) , and recent loss, or decreased expression, of C/EBP␣ in lung cancers has been demonstrated (30) . Decreased levels were more commonly seen in adenocarcinomas and correlated to poor differentiation and a more advanced stage of the tumors. Moreover, forced expression of C/EBP␣ in lung cancer cell lines reduced proliferation and induced morphological changes characteristic of differentiation. All together, this demonstrates a role for C/EBP␣ in regulating cellular proliferation in the lung as well. Together with the role of C/EBP␣ in controlling differentiation-dependent gene expression, this indicates a function for C/EBP␣ as a coordinating regulator of two central parts of differentiation of the lung epithelium: expression of differentiated gene products and induction of growth arrest.
C/EBP␤ and -␦. Present evidence points toward a unique role for C/EBP␣ in regulating proliferation in addition to gene expression. Do the close relatives C/EBP␤ and -␦ have roles of their own in the lung? Certainly they are not vital to baseline lung function and development, as suggested by the findings in mice lacking both C/EBP␤ and -␦, which exhibit no histological abnormalities of the lung (70) . However, when challenged with acute-phase stimuli, C/EBP␤ and -␦ levels are increased in the lung (1). This is reminiscent of the liver, where C/EBP␤ and -␦ are both important regulators of acute-phase genes (56) . Several of the acute-phase protein genes are also expressed in the lung and elevated after lung injury. In addition, collectins expressed in the lung such as SP-A and SP-D are increased after lung injury and, on the basis of this, have been suggested as lung-specific acute-phase proteins (43) . As outlined above, SP-A and SP-D are regulated by C/EBP factors, and this suggests that C/EBPs regulate acute-phase proteins in the lung as well. After lung injury, early inflammatory mediators such as IL-1␤ and TNF-␣ as well as IL-6 and the adhesion molecule ICAM-1 are elevated. Also these genes are C/EBP regulated, further adding to the group of C/EBP-regulated genes that are upregulated in lung injury (13, 24, 56) . Agents apart from classical acute-phase stimuli but also causing acute-lung injury, such as oxidative stress and bleomycin, also increase the levels of C/EBP␤ and -␦ in the lung (1, 14, 69) . This points toward a specific role for C/EBP␤ and -␦ in the reaction to lung injury and the subsequent activation of the innate immune system and inflammatory response.
Glucocorticoids are steroid hormones required for normal lung development. In the absence of glucocorticoid activity, mice die shortly after birth due to respiratory failure. This was clearly demonstrated in knockout mice lacking the glucocorticoid receptor. The lungs of these mice are highly immature with increased proliferation of both mesenchymal and epithelial cells (15) . Treatment with glucocorticoids during embryonic development leads to enhanced lung maturation and increased expression of lung epithelial proteins exhibiting a differentiation-dependent expression pattern. Such proteins include the surfactant proteins and CCSP (11, 45) . Glucocorticoids act through the glucocorticoid receptor, yet the specific molecular mechanisms for the effects of glucocorticoids on lung development are unclear. Direct effects on the lung epithelium are likely, though paracrine signaling between mesenchymal and epithelial cells has also been suggested (45) . Our knowledge of this field was advanced by findings in transgenic mice harboring a mutation in the dimerization domain of the glucocorticoid receptor. This mutation prevents transcriptional regulation by DNA binding but allows regulation by protein-protein interactions. In contrast to the glucocorticoid receptor knockout mice, these mice are viable and do not suffer from respiratory problems (60) . This suggests that direct transcriptional activation by the glucocorticoid receptor is of less importance during lung development and that protein-protein interactions play a more prominent role. In line with this, no functional binding sites for the glucocorticoid receptor have been demonstrated in the promoters of the glucocorticoid-regulated surfactant protein and CCSP genes (33) . In summary, even though glucocorticoids have a central role in lung development, unclear issues still remain about the mechanisms of glucocorticoids signaling in the lung epithelium. Recent observations suggesting a role for C/EBP␤ and -␦ in glucocorticoid signaling in the lung might shed light on this. In a lung epithelial cell line, glucocorticoid stimulation of the CCSP and CYP2B1 promoters was dependent on the integrity of C/EBPbinding sites in the respective promoter. This is similar to findings in liver and adipose tissue, where glucocorticoid hormones also play an important role during cellular differentiation. In these organs, some glucocorticoid effects on gene expression are mediated via C/EBP␤ and -␦ (18, 28, 41) . However, in contrast to these organs, glucocorticoids do not increase the protein levels of C/EBP␤ and -␦ in lung cells. Instead, they enhance DNA-binding activity without affecting protein levels, suggesting glucocorticoid-induced posttranslational modifications that stimulate binding of C/EBP␤ and -␦ to their cognate binding sites in target promoters (4) . Furthermore, in human fetal lung explants, glucocorticoids have been shown to increase C/EBP␦ levels (5). Together, these results indicate a previously unknown role for C/EBP␤ and -␦ in glucocorticoid signal transduction in the lung.
How could the same factors (C/EBP␤ and -␦) be involved in the response to both inflammatory stimuli and a strong anti-inflammatory agent such as glucocorticoids? The findings that C/EBPs are targets for posttranslational modifications such as phosphorylation and sumoylation, which subsequently affect DNA binding and/or transactivation potential, could be part of the answer (34, 58) . Posttranslational modifications have been most studied in C/EBP␤. This protein carries multiple phosphorylation sites that have been demonstrated as targets for a diverse set of signal transduction pathways. For instance, stress-activated protein kinases, such as p38, which are activated by cellular stress and involved in the acute-phase reaction, cause C/EBP␤ phosphorylation on Ser105, inducing the transactivation potential (23) . The same amino acid residue is also a target for PKC phosphorylation (73) . Other described phosphorylation events can decrease transactivation potential, inhibit DNA binding, or affect nucleo-cytoplasmic shuttling of C/EBP␤. Also, C/EBP␦ is a target for regulated phosphorylation, but this has not been studied in the same detail as for C/EBP␤ (58) . The ability of C/EBP␤ and -␦ to undergo posttranslational modifications suggests a potential scenario in which glucocorticoids cause specific posttranslational modifications of C/EBP␤ and -␦ other than those caused by inflammatory stimuli. These events could then target C/EBP␤ and -␦ toward glucocorticoid-regulated lung epithelium-specific genes and away from inflammatory genes.
CONCLUSION
Even though we are far from a complete understanding, a picture is emerging in which C/EBP␣ has a role in directly regulating proliferation as well as differentiation-dependent gene expression. C/EBP␤ and -␦ have a partly overlapping role in regulating expression of differentiation markers but are also involved in responses to different stimuli such as acute lung injury and glucocorticoid hormones. 
